Executive Vice President, Chief Business Officer, Secretary and Director · BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Uri Yablonka

A named executive officer of BRAINSTORM CELL THERAPEUTICS in every fiscal year CompBrief holds from FY2023 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$328,313

Salary $123,565Stock awards $128,400

FY2024: $266,138

2nd of 2 named executive officers at Brainstorm Cell Therapeutics by FY2025 total.

2 named officers on file for BRAINSTORM CELL THERAPEUTICS, FY2025

Uri Yablonka’s pay file — $29

  • 3 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BRAINSTORM CELL THERAPEUTICS’s whole pay program stands against its peers

  • BRAINSTORM CELL THERAPEUTICS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BCLI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 31, 2026 (10-K). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Uri Yablonka’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Uri Yablonka compensation by year

BRAINSTORM CELL THERAPEUTICS Summary Compensation Table · all 3 fiscal years held
In US dollars, as BRAINSTORM CELL THERAPEUTICS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2023FY2024FY2025
Salary$164,780$151,390$123,565
Bonus$0$0$0
Stock awards$0$36,111$128,400
Option awards$0$0$0
Non-equity incentive$0$0$0
Pension and deferred compensation$0$0$0
All other$82,275$78,637$76,348
Total$247,055$266,138$328,313

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BRAINSTORM CELL THERAPEUTICS INC. 10-K filed March 31, 2026, accession 0001104659-26-037927, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BRAINSTORM CELL THERAPEUTICS INC. filed document, accession 0001104659-26-037927. Every figure is read from that document and cited to the page and table it appears in. Filed March 31, 2026.

$247K
$266K
$328K
FY23
FY24
FY25
SalaryStock awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU40,000$22,000—
RSU3,647$2,006—

Per the Outstanding Equity Awards at Fiscal Year-End table in BRAINSTORM CELL THERAPEUTICS INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2025 proxy (filed March 31, 2026)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-02-26Grant or award—150,000$0.00218,464

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

BRAINSTORM CELL THERAPEUTICS’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Chaim LebovitsChief Executive Officer & President$713,341
Uri Yablonka · this pageExecutive Vice President, Chief Business Officer, Secretary and Director$328,313

Board service

BRAINSTORM CELL THERAPEUTICS board · FY2021–FY2024
Director compensation in US dollars, as BRAINSTORM CELL THERAPEUTICS reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024—————
FY2022$0$0$0——
FY2021$0$0$77,900—$77,900

Each year as the company reported it in BRAINSTORM CELL THERAPEUTICS's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: BRAINSTORM CELL THERAPEUTICS pays directors a $0 cash retainer. As stated in BRAINSTORM CELL THERAPEUTICS's FY2024 proxy.

The full BRAINSTORM CELL THERAPEUTICS compensation record

free company brief

This page is one person within BRAINSTORM CELL THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BRAINSTORM CELL THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Uri Yablonka's compensation dossier · One-time report. No refunds.